ArticleMolecular biology reports2026
Exploring the potential involvement of UFSP2 in spindle assembly checkpoint regulation in breast cancer.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUbiquitin‑like modifications, including ubiquitination, SUMOylation, and UFMylation, are essential post‑translational modifications that regulate diverse cellular processes. These modifications are dynamically reversed by their corresponding deconjugating enzymes, including deubiquitinases (DUBs), SUMO proteases, and UFM1‑specific proteases (UFSPs), which fine‑tune protein stability, localization, and signaling. Although these enzymes have been implicated in nucleolar function and DNA repair, their roles in mitotic regulation remain largely unclear. This study aimed to systematically explore the potential functions of deubiquitinase‑related proteases during mitosis in breast cancer. METHODS AND
resultsTranscriptome data from the TCGA‑BRCA cohort were analyzed to evaluate the expression patterns of 112 deubiquitinase‑related proteases. Gene set enrichment analysis (GSEA) identified 95 genes significantly associated with mitotic pathways. Among these candidates, UFSP2 ranked within the top 10% based on mitosis‑related enrichment scores, and its correlated gene set showed the strongest enrichment for mitotic pathways. This pattern was independently observed in the GEO dataset GSE96058. In MCF7 cells, UFSP2 knockdown was associated with increased pH3S10 levels and changes in the abundance of spindle assembly checkpoint (SAC) proteins, including TTK, BUB1, MAD1, and other SAC‑related components. Single‑cell RNA‑seq analysis further revealed that UFSP2 expression is lower in the early portion of the inferred tumor developmental trajectory and increases at later stages, accompanied by higher chromosomal instability scores estimated from CNV‑based analyses. Overall, these UFSP2‑associated transcriptional and phenotypic features may reflect its relevance to early tumor progression and the sustained proliferative capacity observed in later tumor states.
conclusionOur study shows that UFSP2 expression exhibits an observable association with mitosis‑related processes in breast cancer cells, particularly with the abundance of spindle assembly checkpoint (SAC)-associated proteins, suggesting that UFSP2 may participate in maintaining mitotic stability. In addition, differences in UFSP2 expression may correspond to distinct biological features at different tumor stages, indicating that stage‑dependent changes in UFSP2 expression may align with the varying biological demands during tumor development. However, these findings are primarily based on correlative analyses and do not establish a direct causal role for UFSP2 in mitosis or tumor progression. Nevertheless, the consistent associations observed across multiple data layers highlight UFSP2 as a potentially important factor that warrants further investigation in future mechanistic studies.
Indexed as
Identifiers
42430000What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.